United States · FDA National Drug Code directory
Regadenoson
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-1401_67995dbc-0e79-4b3b-a6f8-eaeb5048ff3d
- Product NDC
- 0409-1401
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Regadenoson
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230301
- Source listing expiry
- 20261231
Source-listed ingredients
- REGADENOSON ANHYDROUS — .08 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CARTON in 1 PACKAGE (0409-1401-01) / 1 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC (0409-1401-05) · 0409-1401-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →